DE69611728D1 - N-(4-substituerte benzyl)-2-aminolactamderivate - Google Patents
N-(4-substituerte benzyl)-2-aminolactamderivateInfo
- Publication number
- DE69611728D1 DE69611728D1 DE69611728T DE69611728T DE69611728D1 DE 69611728 D1 DE69611728 D1 DE 69611728D1 DE 69611728 T DE69611728 T DE 69611728T DE 69611728 T DE69611728 T DE 69611728T DE 69611728 D1 DE69611728 D1 DE 69611728D1
- Authority
- DE
- Germany
- Prior art keywords
- pct
- substituted benzyl
- sec
- aminolactam
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9515411.8A GB9515411D0 (en) | 1995-07-27 | 1995-07-27 | N-(4-substituted-benzyl)-2-aminolactam derivatives |
PCT/EP1996/002962 WO1997005111A1 (en) | 1995-07-27 | 1996-07-05 | N-(4-substituted-benzyl)-2-aminolactam derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69611728D1 true DE69611728D1 (de) | 2001-03-08 |
DE69611728T2 DE69611728T2 (de) | 2001-05-10 |
Family
ID=10778351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69611728T Expired - Lifetime DE69611728T2 (de) | 1995-07-27 | 1996-07-05 | N-(4-substituerte benzyl)-2-aminolactamderivate |
Country Status (13)
Country | Link |
---|---|
US (1) | US5912242A (de) |
EP (1) | EP0842152B1 (de) |
JP (1) | JP3939755B2 (de) |
AT (1) | ATE199013T1 (de) |
AU (1) | AU6611696A (de) |
BR (1) | BR9609847A (de) |
CA (1) | CA2226886C (de) |
DE (1) | DE69611728T2 (de) |
ES (1) | ES2154830T3 (de) |
GB (1) | GB9515411D0 (de) |
IL (1) | IL122706A0 (de) |
WO (1) | WO1997005111A1 (de) |
ZA (1) | ZA965997B (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9727523D0 (en) | 1997-12-31 | 1998-02-25 | Pharmacia & Upjohn Spa | Alpha-aminoamide derivatives useful as analgesic agents |
US6426342B2 (en) * | 1999-08-16 | 2002-07-30 | Revaax Pharmaceuticals, Llc | Use of β-lactamase inhibitors as neuroprotectants |
US6489319B2 (en) * | 1999-08-16 | 2002-12-03 | Revaax Pharmaceuticals, Llc | Neurotherapeutic use of carboxypeptidase inhibitors |
NZ517663A (en) * | 1999-08-16 | 2006-02-24 | Revaax Pharmaceuticals Llc | Neurotherapeutic clavulanate composition and method |
JP4350508B2 (ja) | 2001-09-03 | 2009-10-21 | ニユーロン・フアーマシユーテイカルズ・エツセ・ピー・アー | ガバペンチンまたはその類似体とα−アミノアミドとを含む薬剤組成物およびその鎮痛用途 |
EP1438956A1 (de) | 2003-01-16 | 2004-07-21 | Newron Pharmaceuticals S.p.A. | Alpha-Aminoamidderivate die als Antimigränemittel nützlich sind |
US7163937B2 (en) | 2003-08-21 | 2007-01-16 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
EP1524267A1 (de) * | 2003-10-15 | 2005-04-20 | Newron Pharmaceuticals S.p.A. | Substituierte Benzylaminoalkylen-Heterozyklen |
EP1533298A1 (de) * | 2003-11-21 | 2005-05-25 | Newron Pharmaceuticals S.p.A. | 3-aminopyrrolidonederivate |
EP1588704A1 (de) | 2004-04-22 | 2005-10-26 | Newron Pharmaceuticals S.p.A. | Alpha-aminoamidderivate zur Behandlung des Restless-Leg-Syndroms und der Suchterkrankungen |
EP1870097A1 (de) | 2006-06-15 | 2007-12-26 | Newron Pharmaceuticals S.p.A. | Alpha-aminoamidederivate zur Behandlung von kognitiven Störungen |
US7629351B2 (en) | 2006-07-28 | 2009-12-08 | Bristol-Myers Squibb Company | N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-2-oxo-3-(6-(trifluoromethyl)quinazolin-4-ylamino) pyrrolidin-1-yl)cyclohexyl)acetamide and other modulators of chemokine receptor activity, crystalline forms and process |
US7687508B2 (en) | 2006-07-28 | 2010-03-30 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
US7671062B2 (en) | 2006-07-28 | 2010-03-02 | Bristol-Myers Squibb Company | Modulators of chemokine receptor activity, crystalline forms and process |
AU2010242948A1 (en) * | 2009-04-29 | 2011-11-24 | Rexahn Pharmaceuticals, Inc. | Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders |
US8383812B2 (en) | 2009-10-13 | 2013-02-26 | Bristol-Myers Squibb Company | N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU518986B2 (en) * | 1977-10-11 | 1981-10-29 | Takeda Chemical Industries Ltd. | Lactams |
US4719207A (en) * | 1984-06-25 | 1988-01-12 | Yamanouchi Pharmaceutical Co., Ltd. | CNS active substituted azetidinone compounds |
GB8823605D0 (en) * | 1988-10-07 | 1988-11-16 | Merck Sharp & Dohme | Therapeutic agents |
-
1995
- 1995-07-27 GB GBGB9515411.8A patent/GB9515411D0/en active Pending
-
1996
- 1996-07-05 WO PCT/EP1996/002962 patent/WO1997005111A1/en active IP Right Grant
- 1996-07-05 EP EP96925667A patent/EP0842152B1/de not_active Expired - Lifetime
- 1996-07-05 US US08/981,493 patent/US5912242A/en not_active Expired - Lifetime
- 1996-07-05 JP JP50714897A patent/JP3939755B2/ja not_active Expired - Lifetime
- 1996-07-05 BR BR9609847A patent/BR9609847A/pt not_active Application Discontinuation
- 1996-07-05 AT AT96925667T patent/ATE199013T1/de not_active IP Right Cessation
- 1996-07-05 DE DE69611728T patent/DE69611728T2/de not_active Expired - Lifetime
- 1996-07-05 ES ES96925667T patent/ES2154830T3/es not_active Expired - Lifetime
- 1996-07-05 AU AU66116/96A patent/AU6611696A/en not_active Abandoned
- 1996-07-05 IL IL12270696A patent/IL122706A0/xx unknown
- 1996-07-05 CA CA002226886A patent/CA2226886C/en not_active Expired - Lifetime
- 1996-07-15 ZA ZA965997A patent/ZA965997B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2226886A1 (en) | 1997-02-13 |
EP0842152B1 (de) | 2001-01-31 |
ATE199013T1 (de) | 2001-02-15 |
US5912242A (en) | 1999-06-15 |
JPH11509848A (ja) | 1999-08-31 |
WO1997005111A1 (en) | 1997-02-13 |
IL122706A0 (en) | 1998-08-16 |
DE69611728T2 (de) | 2001-05-10 |
BR9609847A (pt) | 1999-03-09 |
AU6611696A (en) | 1997-02-26 |
CA2226886C (en) | 2007-01-30 |
ES2154830T3 (es) | 2001-04-16 |
EP0842152A1 (de) | 1998-05-20 |
JP3939755B2 (ja) | 2007-07-04 |
GB9515411D0 (en) | 1995-09-27 |
ZA965997B (en) | 1997-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69611728D1 (de) | N-(4-substituerte benzyl)-2-aminolactamderivate | |
NO306346B1 (no) | N-substituerte azabicykloalkanderivater, anvendelse derav og farmasöytisk preparat | |
NO963850D0 (no) | Heterosykliske forbindelser, deres fremstilling og anvendelse | |
BR9611175B1 (pt) | compostos e composiÇÕes farmacÊuticas. | |
NO963053L (no) | Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav | |
FR2743562B1 (fr) | Derives de n-(arylsulfonyl) aminoacides, leur preparation, les compositions pharmaceutiques en contenant | |
MXPA02001340A (es) | Compuestos novedosos 1,4-benzodiazepina y derivados de los mismos. | |
FI972434A (fi) | Lamotrigiiniä sisältävä farmaseuttinen koostumus | |
DK0810991T3 (da) | 1-Aryl-2-acylamino-ethan-forbindelser og deres anvendelse som neurokinin- især neurokinin-1-antagonister | |
ATE233246T1 (de) | Hydantoinderivate als zwischenprodukte für pharmazeutische wirkstoffe | |
DK0891341T3 (da) | 1,3,4-Oxadiazinderivater samt deres anvendelse som pesticider | |
NO306400B1 (no) | N-substituerte azabicykloheptan-derivater, anvendelse derav og farmasöytisk preparat | |
DK0775143T3 (da) | 3-substituerede 3H-2,3-benzodiazepinderivater, deres fremstilling og anvendelse som lægdemidler | |
BR9610175A (pt) | Composto processo de preparação do composto composição farmacêutica e utilização do composto | |
PL323305A1 (en) | Applications of allyl amines | |
DK0805817T3 (da) | Thiolderivater med metallopeptidaseinhiberende aktivitet | |
DK0815109T3 (da) | Fremgangsmåde til fremstilling af estere af anhydroecgonin | |
ZA955052B (en) | Pyrrolidine derivatives their preparation and compositions containing them | |
CA2241788A1 (fr) | Nouveaux derives de n-(arylsulfonyl)aminoacides, leur procede de preparation et compositions pharmaceutiques en contenant |